131 related articles for article (PubMed ID: 6778293)
41. C1 dissociation in serum: estimation of free C1q by electroimmunoassay.
Sjöholm AG; Mårtensson U; Laurell AB
Acta Pathol Microbiol Immunol Scand C; 1985 Aug; 93(4):161-8. PubMed ID: 3876685
[TBL] [Abstract][Full Text] [Related]
42. Assembly of subcomponents C1r and C1s of first component of complement: electron microscopic and ultracentrifugal studies.
Tschopp J; Villiger W; Fuchs H; Kilchherr E; Engel J
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7014-8. PubMed ID: 6938949
[TBL] [Abstract][Full Text] [Related]
43. The first component of human complement (C1): activation and control.
Ziccardi RJ
Springer Semin Immunopathol; 1983; 6(2-3):213-30. PubMed ID: 6314572
[TBL] [Abstract][Full Text] [Related]
44. Activation of C1r by proteolytic cleavage.
Ziccardi RJ; Cooper NR
J Immunol; 1976 Feb; 116(2):504-9. PubMed ID: 1249422
[TBL] [Abstract][Full Text] [Related]
45. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
Sturfelt G; Sjöholm AG
Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
[TBL] [Abstract][Full Text] [Related]
46. The identification of a previously unrecognized subcomponent of the first component of complement.
Assimeh SN; Painter RH
J Immunol; 1975 Aug; 115(2):482-7. PubMed ID: 807639
[TBL] [Abstract][Full Text] [Related]
47. Structural features of the first component of human complement, C1, as revealed by surface iodination.
Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
[TBL] [Abstract][Full Text] [Related]
48. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
Katz Y; Strunk RC
J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
[TBL] [Abstract][Full Text] [Related]
50. The role of immune complexes in the activation of the first component of human complement.
Ziccardi RJ
J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
[TBL] [Abstract][Full Text] [Related]
51. Dissociation of C1 and concentration dependence of its activation kinetics.
Kilchherr E; Fuchs H; Tschopp J; Engel J
Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
[TBL] [Abstract][Full Text] [Related]
52. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
Boackle RJ; Connor MH; Vesely J
Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
[TBL] [Abstract][Full Text] [Related]
53. A molecular mechanism for the activation of the first component of complement by immune complexes.
Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
[TBL] [Abstract][Full Text] [Related]
54. Deficiency of the first component of human complement.
Reid KB
Immunodefic Rev; 1989; 1(3):247-60. PubMed ID: 2561058
[TBL] [Abstract][Full Text] [Related]
55. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
[TBL] [Abstract][Full Text] [Related]
56. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
[TBL] [Abstract][Full Text] [Related]
57. Subunit interactions in the first component of complement, C1.
Lakatos S
Biochem Biophys Res Commun; 1987 Dec; 149(2):378-84. PubMed ID: 2827640
[TBL] [Abstract][Full Text] [Related]
58. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
[TBL] [Abstract][Full Text] [Related]
59. Evidence that C1s participates in the alternative complement pathway.
Volanakis JE; Schultz DR; Stroud RM
Int Arch Allergy Appl Immunol; 1976; 50(1):68-80. PubMed ID: 1244208
[TBL] [Abstract][Full Text] [Related]
60. The relationship between the binding ability and the rate of activation of the complement component C1.
Folkerd EJ; Gardner B; Hughes-Jones NC
Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
